Project Grant R03EB034817

Award Date 5/1/24
Completion Date 3/31/26
Dollars Obligated $371K
Federal Grant Program
93.286
Assistance Type
Project Grant
Place of Performance
Colorado Springs, CO 80918, USA
Similar Awards
The National Center for Advancing Translational Sciences (NCATS) awarded a $275,000 Project Grant (CFDA 93.350) to Nectagen Inc. to develop bioprocess-compatible, second-generation nanoclamp affinity resins for the efficient purification of plasma-based therapeutic proteins. The goal is to identify panels of nanoclamps to 5 industrially relevant plasma-based therapeutics, select lead candidates, and optimize the resins for maximum recovery and purity from plasma samples. This project aims to...
This Project Grant award from the National Science Foundation's Division of Chemical, Bioengineering, Environmental, and Transport Systems (CFDA 47.041 - Engineering) provides $154,577 to Duke University to develop machine learning algorithms for predicting protein-nanoparticle interactions. The research team will characterize protein adsorption on nanoparticles with varying properties and train machine learning models to forecast protein corona formation. The project aims to promote the safe...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) under CFDA 93.859 Biomedical Research and Research Training program provides $306,860 to Mixedlcmedia LLC, a small disadvantaged business, to develop and evaluate a prototype ultra-low flow liquid chromatography platform based on their proprietary porous layer open-tubular (PLOT) and monolithic nanocolumn technologies. The goal is to create a commercialization-ready LC system that enables deep proteomic...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training Program (CFDA 93.859) provides $295,561 to Biosensing Instrument Inc. to develop a commercial prototype of their Plasmonic Scattering Microscopy (PSM) technology. The PSM system aims to enable high-throughput, label-free quantification of membrane protein binding kinetics on single cells in their native cellular microenvironment. This represents a...
This $337,863 Project Grant awarded by the National Science Foundation's (NSF) Division of Chemistry under the Mathematical and Physical Sciences program (CFDA 47.049) supports research by Professor Ken Marcus and his team at Clemson University to develop new methods for isolating and purifying diverse biological nanoparticles, including exosomes, lentiviruses, and adeno-associated viruses. The researchers aim to characterize and implement a unique fiber-based stationary phase,...
This $415,830 Project Grant award from the National Cancer Institute (NCI), under the Cancer Detection and Diagnosis Research program (CFDA 93.394), aims to develop an integrated nanoplasmonic sensing platform termed "Nano-CRISPR" for longitudinal tumor monitoring in ovarian cancer patients. The key products and services to be delivered include: Incorporation of single extracellular vesicle (EV) capture and analysis using plasmonic nanodisk arrays, CRISPR/Cas13a sensors for lysis-free,...
This federal Project Grant award of $338,843 from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) aims to develop an electrospray differential mobility analysis (ES-DMA) soft landing system to enable better structural preservation and higher resolution cryo-electron microscopy (cryo-EM) analysis of clinically relevant protein targets. The research team from Nanoengineering Corporation and the University of...
This National Science Foundation (NSF) Engineering program Project Grant awarded to West Virginia University Research Corporation, with a total funding amount of $348,987, will fund research to investigate how the physical characteristics of metal oxide nanoparticles used as MRI contrast agents impact their interactions with neutrophils and platelets. The central hypothesis is that nanoparticle properties such as metal content, surface coating, and size can modulate neutrophil and platelet...
This Project Grant award of $851,000 from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), aims to develop a novel research tool to support accurate and efficient biodistribution studies of gene-carrying nanoparticles. The key products and services to be delivered include: Synthesis of a library of deuterated peptoid-based barcodes that can be co-loaded...
The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a $391,588 Project Grant under the "Discovery and Applied Research for Technological Innovations to Improve Human Health" (CFDA 93.286) program to The Methodist Hospital Research Institute (HMRI) in Houston, TX. The grant supports the development of an artificial intelligence-integrated physiologically-based pharmacokinetic (PBPK) model to enable rational design of nanoparticles for improved organ targeting...

HETEROGENEITY OF PROTEIN CORONA (PC) COMPOSITION USING HIGHLY SENSITIVE MAGNETIC LEVITATION (MAGLEV) SYSTEM - ABSTRACT THE EVOLUTION OF PC (LAYER OF PROTEINS/BIOMOLECULES THAT ADSORBS AT THE SURFACE OF NPS UPON CONTACT BY BIOLOGICAL FLUIDS) IN VIVO STILL REMAINS HIGHLY CHALLENGING DUE TO THE COMPLEXITY OF HUMAN PHYSIOLOGY, THE COMPLEX NATURE OF THE BIOMOLECULES ADSORBS ON THE SURFACE, WHICH IS ONE OF THE MAIN BARRIERS OF CLINICAL TRANSLATION OF NANOMATERIALS. THE EX VIVO APPROACHES FOR PREPARATION OF PC ON THE SURFACE OF THE MODEL NPS DO NOT PROVIDE HOMOGENOUS CORONA FORMATION AS COMMONLY PERCEIVED IN THE LITERATURE AND THE COMPOSITION OF THE PC VARIES EVEN ACROSS IDENTICAL NPS WITH THE SAME SIZES IN THE SAME BATCH AND USING THE SAME BIOLOGICAL FLUID. THE CURRENT AVAILABLE PC CHARACTERIZATIONS OR ISOLATION TECHNIQUES ARE NOT ABLE TO DETECT SMALL VARIATIONS IN THE COMPOSITION OF THE PC AND HETEROGENEITY OF THE PC STRUCTURE. THEREFORE, NON-SPECIFIC EXTRACTION AND POOL ANALYSIS OF THE PC IN EX VIVO CONDITION MAY CAUSE ERROR AND/OR MISINTERPRETATION OF THE PC OUTCOMES WHICH SIGNIFICANTLY INFLUENCE THE CLINICAL TRANSLATION OF NPS. WE SHOW IN THE PRELIMINARY DATA THAT ALTHOUGH THE STANDARD MAGLEV SYSTEMS ARE ABLE TO SEPARATE PC COATED AND UNCOATED NPS HOWEVER, IT IS NOT ABLE TO DISCRIMINATE AMONG PC COATED NPS WITH VARIOUS PC COMPOSITION AT THE SURFACE OF THE NPS DUE THEIR VERY SIMILAR DENSITY AND LOW RESOLUTION OF THE STANDARD MAGLEV SYSTEMS. IN THIS EXPLORATORY RESEARCH WE AIM TO DEVELOP A HIGHER SENSITIVITY MAGLEV SYSTEM TO SHOW THE HETEROGENEITY AND VARIATION OF PC COMPOSITION ON THE SURFACE OF THE NPS, A CRITICAL IGNORED FACTOR IN CLINICAL TRANSLATION OF NANOMATERIALS AND FAILURES OF NANOMEDICINE. IN SUCH HIGHLY SENSITIVE MAGLEV CONFIGURATION, THE RESOLUTION ENHANCES 1 TO 3 ORDERS OF MAGNITUDE (COMPARED WITH SENSITIVITY OF STANDARD MAGLEV SYSTEM (I.E., 10-3 G/CM3)) WHICH IS HIGH ENOUGH TO SEPARATE PC COATED NPS WITH DIFFERENT PC COVERAGES/COMPOSITIONS (E.G., NUMBER AND TYPE OF THE PROTEINS AT THE SURFACE) AND VERY SLIGHT DIFFERENCES IN THE DENSITY (RANGING FROM 0.001 G/CM3 TO 0.00001 G/CM3 WHICH IS NOT DETECTABLE USING STANDARD MAGLEV SYSTEM). OUR PRELIMINARY DATA USING A PROTOTYPE HIGH SENSITIVITY MAGLEV SYSTEM AS PROOF-OF-CONCEPT, CONFIRMS THAT HOW IDENTICAL OBJECTS (I.E., COMMERCIAL IDENTICAL NYLON PARTICLES) WITH THE SAME DENSITY AND LEVITATION HEIGHTS IN THE STANDARD MAGLEV SYSTEM HAVE SIGNIFICANT DIFFERENT LEVITATION HEIGHTS IN A HIGH SENSITIVITY (PROTOTYPE) MAGLEV SYSTEM INDICATING LOW RESOLUTION OF THE STANDARD OF THE MAGLEV SYSTEMS TO DETECT SUCH SMALL VARIATIONS/CHANGES. THE CURRENT STATE-OF- THE-ART IN THIS TYPE OF SEPARATION IS THAT THERE ARE SIMPLE PROOFS-OF-CONCEPT OF MANY OF ITS FOUNDATIONAL CONCEPTS, BUT LITTLE USE OF FULLY DEVELOPED METHODS BY BIOLOGISTS AND CLINICIANS. THIS PROJECT WILL BOTH SOLIDIFY THE FUNDAMENTAL BIOPHYSICAL SCIENCE OF MAGLEV AS A SIMPLE ANALYTICAL TOOL IN BIOCHEMISTRY AND PROVIDE DEMONSTRATIONS OF USES FOR NANOMEDICINE APPLICATIONS.

Posted 4/26/24, 12:00 AM